Immunocompetent PDMS-Free Organ-on-Chip Model of Cervical Cancer Integrating Patient-Specific Cervical Fibroblasts and Neutrophils

被引:3
|
作者
Kromidas, Elena [1 ]
Geier, Alicia [1 ]
Weghofer, Adrian [1 ]
Liu, Hui-Yu [1 ]
Weiss, Martin [2 ,3 ]
Loskill, Peter [1 ,2 ,4 ]
机构
[1] Eberhard Karls Univ Tubingen, Inst Biomed Engn, Fac Med, Dept Microphysiol Syst, D-72074 Tubingen, Germany
[2] Univ Tubingen, Dept Biomed & Mat Sci, NMI Nat & Med Sci Inst, D-72770 Reutlingen, Germany
[3] Eberhard Karls Univ Tubingen, Fac Med, Dept Womens Hlth, D-72076 Tubingen, Germany
[4] 3R Ctr Tubingen Vitro Models & Alternat Anim Testi, D-72074 Tubingen, Germany
关键词
cancer-on-chip; cervical cancer; cisplatin; microphysiological systems; neutrophils; organ-on-chip; TUMOR-ASSOCIATED NEUTROPHILS; HUMAN-PAPILLOMAVIRUS; EXTRACELLULAR TRAPS; CARCINOMA-CELLS; TUMORIGENESIS; ACTIVATION; CROSSTALK; INVASION; GROWTH; STROMA;
D O I
10.1002/adhm.202302714
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Despite preventive measures and available treatments, cervical cancer still ranks as the fourth most prevalent cancer among women worldwide and remains the leading cause of cancer death in women in many developing countries. To gain further insights into pathogenesis and to develop novel (immuno)therapies, more sophisticated human models recreating patient heterogeneities and including aspects of the tumor microenvironment are urgently required. A novel polydimethylsiloxane-free microfluidic platform, designed specifically for the generation and ccultivation of cervical cancerous tissue, is introduced. The microscale open-top tissue chambers of the cervical cancer-on-chip (CCoC) enable facile generation and long-term cultivation of SiHa spheroids in co-culture with donor-derived cervical fibroblasts. The resulting 3D tissue emulates physiological architecture and allows dissection of distinct effects of the stromal tissue on cancer viability and growth. Treatment with cisplatin at clinically-relevant routes of administration and dosing highlights the platform's applicability for drug testing. Moreover, the model is amenable for integration and recruitment of donor-derived neutrophils from the microvasculature-like channel into the tissue, all while retaining their ability to produce neutrophil extracellular traps. In the future, the immunocompetent CCoC featuring donor-specific primary cells and tumor spheroids has the potential to contribute to the development of new (immuno)therapeutic options. Cervical cancer still ranks as the fourth most prevalent cancer among women and remains the leading cause of cancer death in women in a wide range of developing countries. Hence, the cervical cancer-on-chip, a novel PDMS-free microfluidic platform designed specifically for the generation and cultivation of cervical cancerous tissue and perfusion of circulating immune cells, is developed.image
引用
收藏
页数:18
相关论文
共 21 条
  • [21] STAT3 inhibitor BBI608 reduces patient-specific primary cell viability of cervical and endometrial cancer at a clinical-relevant concentration
    Chen, Jing
    Huang, Shuting
    Li, Huawen
    Li, Yun
    Zeng, Haishan
    Hu, Jiemei
    Lin, Yanchun
    Cai, Huihua
    Deng, Pengfei
    Song, Ting
    Guan, Tian
    Zeng, Haoyu
    Liu, Mubiao
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2023, 25 (03): : 662 - 672